MedTrace Logo

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

NCT00002366 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2009-02-20

No results posted yet for this study

Summary

To evaluate the safety and anti-Kaposi's sarcoma activity of ritonavir.

Conditions

  • Sarcoma, Kaposi
  • HIV Infections

Interventions

DRUG

Ritonavir

Sponsors & Collaborators

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002366 on ClinicalTrials.gov